v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash $ 1,371,945
Prepaid expenses 80,165 25,000
Total Current Assets 1,452,110 25,000
Long-term prepaid insurance 48,588
Deferred offering costs 336,830
Investments held in Trust Account 231,832,551
Total Assets 233,333,249 361,830
Current liabilities    
Accrued expenses 56,244 25,491
Accrued offering costs 85,000 258,895
Total Current Liabilities 141,244 400,221
Deferred legal fees 153,291
Deferred underwriting fee payable 12,650,000
Total Liabilities 12,944,535 400,221
Commitments and Contingencies (Note 7)
Class A ordinary shares subject to possible redemption, 23,000,000 and no shares at a redemption value of $10.06 and $0 per share as of June 30, 2026 and December 31, 2025, respectively 231,457,551
Shareholders’ Deficit:    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital 24,425
Accumulated deficit (11,069,436) (63,391)
Total Shareholders’ Deficit (11,068,837) (38,391)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit 233,333,249 361,830
Related Party    
Current liabilities    
Promissory note – related party 115,835
Class A ordinary shares    
Shareholders’ Deficit:    
Ordinary shares value 24
Class B ordinary shares    
Shareholders’ Deficit:    
Ordinary shares value [1] $ 575 $ 575
[1] This number includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture by the Sponsor if the over-allotment option was not exercised in full or in part by the underwriter (Note 6). On March 30, 2026, the Company issued an aggregate of 120,000 founder shares to its three independent directors, with each director receiving 40,000 shares, at a purchase price of approximately $0.004 per share for an aggregate purchase price of $522. In connection with these issuances, the Sponsor surrendered to the Company, for no consideration, an equal number of founder shares. On April 15, 2026, the underwriter notified the Company of its intent to exercise its over-allotment option in full and on April 20, 2026, the underwriter purchased an additional 3,000,000 units. As such, the 750,000 Class B ordinary shares are no longer subject to forfeiture.